HCV as a favorable prognostic factor in HCC treated with SBRT: systematic review and meta-analysis

被引：0
|
作者：
Greenberg, Lily [1 ]
Kabarriti, Rafi [2 ]
Tang, Justin [2 ]
Kaubisch, Andreas [3 ]
Kuang, Chaoyuan [3 ]
Bteich, Fernand [3 ]
Kinkhabwala, Milan [4 ]
Guha, Chandan [2 ]
Ohri, Nitin [2 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY USA
[2] Montefiore Einstein Comprehens Canc Ctr, Radiat Oncol, Bronx, NY USA
[3] Montefiore Einstein Comprehens Canc Ctr, Hematol Oncol, Bronx, NY USA
[4] Montefiore Med Ctr, Surg, Bronx, NY USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
Hepatitis C Virus; Hepatocellular Carcinoma; SBRT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1845
引用
收藏
页码：S2210 / S2213
页数：5
相关论文
共 50 条
  • [21] Outcomes of direct-acting antivirals in patients with HCV decompensated cirrhosis: a systematic review and meta-analysis
    Jongraksak, Tanawat
    Chuncharunee, Alan
    Intaraprasong, Pongphob
    Tansawet, Amarit
    Thakkinstian, Ammarin
    Sobhonslidsuk, Abhasnee
    FRONTIERS IN MEDICINE, 2023, 10
  • [22] Is tumor necrosis a clinical prognostic factor in hepato-biliary-pancreatic cancers? A systematic review and meta-analysis
    Yang, Siqi
    Hu, Haijie
    Hu, Yafei
    Dai, Yushi
    Zou, Ruiqi
    Lv, Tianrun
    Li, Fuyu
    CANCER MEDICINE, 2023, 12 (10): : 11166 - 11176
  • [23] Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis
    Dong Wook Kim
    Sang Hyun Choi
    So Yeon Kim
    Jae Ho Byun
    Seung Soo Lee
    Seong Ho Park
    Kyung Won Kim
    Hepatology International, 2020, 14 : 1009 - 1022
  • [24] The prognostic significance of prognostic nutritional index in gastrointestinal stromal tumors: A systematic review and meta-analysis
    Li, Zhenjie
    Zhang, Dengming
    Mo, Chunlin
    Zhu, Peijin
    Fan, Xiaoxi
    Tang, Tingyong
    MEDICINE, 2022, 101 (47) : E32067
  • [25] Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis
    Mao, Xianhua
    Cheung, Ka Shing
    Peng, Chengzhi
    Mak, Lung-Yi
    Cheng, Ho Ming
    Fung, James
    Peleg, Noam
    Leung, Howard H-W
    Kumar, Rajneesh
    Lee, Jeong-Hoon
    Shlomai, Amir
    Yuen, Man-Fung
    Seto, Wai-Kay
    HEPATOLOGY, 2023, 77 (05) : 1735 - 1745
  • [26] TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis
    Chen, Bin
    Pang, Long
    Chen, Hao-Bin
    Wu, Dong-Bo
    Wang, Yong-Hong
    Chen, En-Qiang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (03) : 232 - 237
  • [27] Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis
    Kim, Dong Wook
    Choi, Sang Hyun
    Kim, So Yeon
    Byun, Jae Ho
    Lee, Seung Soo
    Park, Seong Ho
    Kim, Kyung Won
    HEPATOLOGY INTERNATIONAL, 2020, 14 (06) : 1009 - 1022
  • [28] Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: A systematic review and meta-analysis
    Wang, Jing
    Feng, Lingxin
    Zhang, Linwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (01)
  • [29] Prognostic value of osteopontin in patients with hepatocellular carcinoma A systematic review and meta-analysis
    Sun, Tingting
    Li, Peng
    Sun, Diwen
    Bu, Qingao
    Li, Guoqiang
    MEDICINE, 2018, 97 (43)
  • [30] The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
    Yu, Min
    Han Yongzhi
    Chen, Shengying
    Luo, Xiaodan
    Lin, Ye
    Zhou, Yu
    Jin, Haosheng
    Hou, Baohua
    Deng, Yanying
    Tu, Lei
    Jian, Zhixiang
    ONCOTARGET, 2017, 8 (26) : 43356 - 43367
12345